| Literature DB >> 34242795 |
Mahfoozur Rahman1, Waleed H Almalki2, Saad Alghamdi3, Khalid S Alharbi4, Habibullah Khalilullah5, Md Habban Akhter6, Amit K Keshari6, Nisha Sharma6, Tanuja Singh7, Kriti Soni8, Abdul Hafeez9, Sarwar Beg10.
Abstract
The development of pharmaceutical drug products is required for the treatment of disease, which has resulted in an increasing number of approvals by regulatory agencies across the globe. To establish a hassle-free manufacturing process, the systematic use of a quality-by-design (QbD) approach combined with process analytical technology (PAT) and printing techniques can revolutionize healthcare applications. Printing technology has been emerged in various dimensions, such as 3D, 4D, and 5D printing, with respect to their production capabilities, durability, and accuracy of pharmaceutical manufacturing, which can efficiently deliver novel patient-centric healthcare products with holistic characteristics. In this review, we provide current trends in pharmaceutical product development using a design approach and high-quality printing techniques.Entities:
Keywords: 3D-printing technology; 4D-printing technology; Controlled drug delivery; Nanomedicines; Quality by design
Mesh:
Substances:
Year: 2021 PMID: 34242795 DOI: 10.1016/j.drudis.2021.06.016
Source DB: PubMed Journal: Drug Discov Today ISSN: 1359-6446 Impact factor: 7.851